R.PR
REGISTERED-PRINCIPAL REGISTER
11/01/2022
Voltar para busca
Dado oficial do USPTO
EUROLABOFFICE
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
EUROLABOFFICE
ST13
US500000088320499Classe
9, 42
Pedido
88320499
Registro
6610479
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
47
Atualização mais recente
11/01/2022
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
9, 42
Data de depósito
28/02/2019
Data de registro
11/01/2022
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
11/01/2022
Última transação
11/01/2022
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use, Foreign priority
Primeiro uso
20/11/2018
Primeiro uso no comércio
20/11/2018
Código do desenho
4
Tipo de titular
25
Localização do titular
Lübeck, DE
Examinador
SINGER, MELANIE
Unidade examinadora
M30
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
EUROIMMUN Medizinische Labordiagnostika AG
Representantes
Kevan L. Morgan SEED IP LAW GROUP LLP
Classificação técnica
Classes Nice
Classe 9Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 9
(Based on 44(e)) Measuringdetecting and monitoring instrumentsmeasuringdetecting and monitoring devicesmeasuringdetecting and monitoring regulatorsfor preparingprocessing and evaluating diagnostic samplesfor detecting allergiesneurological diseasesmetabolic diseasesinfectious diseasesautoimmune diseases and cancer; Sensors and detectorsin particular UV fluorescence and chemiluminescence detectors for preparingprocessing and evaluating diagnostic samples; Apparatus for recordingtransmission and reproduction of diagnostic datasound and imagesin particular camerasmicroscopesphotometersmicroplate photometersenzyme-linked immunosorbent assay readersphotomultipliersmicroplate readers; (Based on Use in Commerce) Recorded softwaredownloadable softwaresoftware recorded on mediain particular laboratory softwareimmunofluorescence positioning software and software for evaluating diagnostic samples for the purpose of detecting allergiesneurological diseasesmetabolic diseasesinfectious diseasesautoimmune diseases and cancer
Classe 42
(Based on 44(e)) Scientific services and researchin particular scientific services for evaluating diagnostic samples for the purpose of detecting allergiesneurological diseasesmetabolic diseasesinfectious diseasesautoimmune diseases and cancer; Industrial analysis in the nature of analysis of industrial and medical fluids and reagents; Scientific research servicesin particular research services for evaluating diagnostic samples for detecting allergiesneurological diseasesmetabolic diseasesinfectious diseasesautoimmune diseases and cancer; Design and development of computer hardware and softwarein particular laboratory softwareimmunofluorescence positioning software and software for evaluating diagnostic samples for detecting allergiesneurological diseasesmetabolic diseasesinfectious diseasesautoimmune diseases and cancer; (Based on Use in Commerce) Providing on-line non-downloadable softwarelaboratory softwareimmunofluorescence positioning software and software for evaluating diagnostic samples for the purpose of detecting allergiesneurological diseasesmetabolic diseasesinfectious diseasesautoimmune diseases and cancer
Publicações
Histórico de despachos e eventos da marca no USPTO.
47 publicações encontradas
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
26/10/2021
PUBO
PUBLISHED FOR OPPOSITION
26/10/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
06/10/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
20/09/2021
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
13/07/2021
AAUA
NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED
16/06/2021
IUAA
USE AMENDMENT ACCEPTED
15/06/2021
AUPC
AMENDMENT TO USE PROCESSING COMPLETE
22/04/2021
IUAF
USE AMENDMENT FILED
22/04/2021
EAAU
TEAS AMENDMENT OF USE RECEIVED
21/04/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
18/03/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
17/03/2021
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
17/03/2021
RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
25/08/2020
ALIE
ASSIGNED TO LIE
06/08/2020
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
17/01/2020
GNSL
LETTER OF SUSPENSION E-MAILED
17/01/2020
CNSL
SUSPENSION LETTER WRITTEN
17/01/2020
XAEC
EXAMINER'S AMENDMENT ENTERED
17/01/2020
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
17/01/2020
GNEA
EXAMINERS AMENDMENT E-MAILED
17/01/2020
CNEA
EXAMINERS AMENDMENT -WRITTEN
17/01/2020
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
06/01/2020
GNSL
LETTER OF SUSPENSION E-MAILED
06/01/2020
CNSL
SUSPENSION LETTER WRITTEN
06/01/2020
XAEC
EXAMINER'S AMENDMENT ENTERED
06/01/2020
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
06/01/2020
GNEA
EXAMINERS AMENDMENT E-MAILED
06/01/2020
CNEA
EXAMINERS AMENDMENT -WRITTEN
06/01/2020
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
06/12/2019
GNSL
LETTER OF SUSPENSION E-MAILED
06/12/2019
CNSL
SUSPENSION LETTER WRITTEN
06/12/2019
XAEC
EXAMINER'S AMENDMENT ENTERED
06/12/2019
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
06/12/2019
GNEA
EXAMINERS AMENDMENT E-MAILED
06/12/2019
CNEA
EXAMINERS AMENDMENT -WRITTEN
06/12/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/11/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/11/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
07/11/2019
DOCK
ASSIGNED TO EXAMINER
09/07/2019
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
09/05/2019
GNRT
NON-FINAL ACTION E-MAILED
09/05/2019
CNRT
NON-FINAL ACTION WRITTEN
09/05/2019
DOCK
ASSIGNED TO EXAMINER
09/05/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
20/03/2019
NWAP
NEW APPLICATION ENTERED
04/03/2019
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace EUROLABOFFICE ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.